title: Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line.
abstract: The clinical and epidemiologic features of respiratory syncytial virus (RSV) infections suggest that RSV-specific antibody may sometimes contribute to the disease process. Recently, it has been demonstrated that virus-specific antibody can enhance RSV infection of macrophagelike cells in vitro. We evaluated the possibility that antibody might also enhance RSV stimulation of the bronchoactive mediator of inflammation leukotriene C-4 (LTC4)in a macrophagelike cell line, U937. The addition of RSV led to little increase in LTC4 production, but addition of RSV plus anti-RSV antibody increased production to a level similar to that achieved with calcium ionophore, a known stimulator of LTC4 production. The antibody-enhanced increase in LTC4 production occurred rapidly (within 15 min), peaked at 60 min, and achieved levels 1.5- to 3.0-fold above that for cells or cells plus virus. RSV plus anti-RSV antibodies in the form of polyclonal serum, monoclonal antibodies, or F(ab')2 fragments and parainfluenza virus types 1 and 3 plus their respective antibodies all increased LTC4 levels over that for the virus alone. These results demonstrate that antibody plus the corresponding virus or protein can increase leukotriene production. This phenomenon could contribute to diseases, such as RSV bronchiolitis, that appear to be caused by an interaction between the virus (or antigen) and host immunity.
authors.affiliation: Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
authors.forename: G A
authors.initials: GA
authors.lastname: Ananaba
authors.forename: L J
authors.initials: LJ
authors.lastname: Anderson
mesh_terms: D000914:Antibodies, Viral / Q000276:immunology*; D000937:Antigen-Antibody Reactions; D000956:Antigens, Viral / Q000276:immunology; D002460:Cell Line; D004306:Dose-Response Relationship, Immunologic; D015707:HN Protein; D006801:Humans; D008264:Macrophages / Q000276:immunology / Q000378:metabolism* / Q000382:microbiology; D011961:Receptors, Fc / Q000502:physiology; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D010253:Respirovirus Infections / Q000276:immunology*; D013189:SRS-A / Q000096:biosynthesis*; D013997:Time Factors; D014759:Viral Envelope Proteins / Q000494:pharmacology; D014764:Viral Proteins
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral; D015707:HN Protein; D011961:Receptors, Fc; D013189:SRS-A; D014759:Viral Envelope Proteins; D014764:Viral Proteins; C116204:attachment protein G